Incyte Corporation
Incyte Corporation Incyte Corporation is a Delaware-based biopharmaceutical company that innovates, develops, and markets proprietary therapeutics. Its main focus is to bring out new products for unmet needs. Recently, an Incyte press release announced that it has received approval for Tabrecta, an inhibitor that for mutation-positive and recurrent nonresectable non-small cell lung cancer. The approval […]
